Baxalta Inc Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 112 rows in 2016. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2016-06-03: Reporting owner Goff Brian; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2016-06-03: Reporting owner Goff Brian; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2016-06-03: Reporting owner Goff Brian; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2016-06-03: Reporting owner Goff Brian; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2016-06-03 | Goff Brian Officer (EVP and President, Hematology) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −37,000 0 owned after | $23.15 exercise price | 2016-06-07 | |
| 2016-06-03 | Goff Brian Officer (EVP and President, Hematology) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −25,773 0 owned after | $32.42 exercise price | 2016-06-07 | |
| 2016-06-03 | Goff Brian Officer (EVP and President, Hematology) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −31,376 0 owned after | $31.86 exercise price | 2016-06-07 | |
| 2016-06-03 | Goff Brian Officer (EVP and President, Hematology) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −88,168 0 owned after | $32.04 exercise price | 2016-06-07 | |
| 2016-06-03 | Goff Brian Officer (EVP and President, Hematology) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −35,170 0 owned after | $31.50 exercise price | 2016-06-07 | |
| 2016-06-03 | Goff Brian Officer (EVP and President, Hematology) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −265,221 0 owned after | $31.50 exercise price | 2016-06-07 | |
| 2016-06-03 | HOMBACH ROBERT J. Officer (EVP. CFO and COO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −49,628 0 owned after | $24.83 exercise price | 2016-06-07 | |
| 2016-06-03 | HOMBACH ROBERT J. Officer (EVP. CFO and COO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −88,597 0 owned after | $26.53 exercise price | 2016-06-07 | |
| 2016-06-03 | HOMBACH ROBERT J. Officer (EVP. CFO and COO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −95,163 0 owned after | $32.42 exercise price | 2016-06-07 | |
| 2016-06-03 | HOMBACH ROBERT J. Officer (EVP. CFO and COO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −103,181 0 owned after | $31.86 exercise price | 2016-06-07 | |
| 2016-06-03 | HOMBACH ROBERT J. Officer (EVP. CFO and COO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −287,936 0 owned after | $32.04 exercise price | 2016-06-07 | |
| 2016-06-03 | HOMBACH ROBERT J. Officer (EVP. CFO and COO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −35,170 0 owned after | $31.50 exercise price | 2016-06-07 | |
| 2016-06-03 | HOMBACH ROBERT J. Officer (EVP. CFO and COO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −380,535 0 owned after | $31.50 exercise price | 2016-06-07 | |
| 2016-06-03 | GLASSPOOL JOHN Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,000 0 owned after | $30.37 exercise price | 2016-06-07 | |
| 2016-06-03 | GLASSPOOL JOHN Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −14,274 0 owned after | $32.42 exercise price | 2016-06-07 | |
| 2016-06-03 | GLASSPOOL JOHN Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,929 0 owned after | $31.86 exercise price | 2016-06-07 | |
| 2016-06-03 | GLASSPOOL JOHN Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −55,104 0 owned after | $32.04 exercise price | 2016-06-07 | |
| 2016-06-03 | GLASSPOOL JOHN Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −23,447 0 owned after | $31.50 exercise price | 2016-06-07 | |
| 2016-06-03 | LEONARDI JACOPO Officer (EVP and President, Immunology) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,051 0 owned after | $26.53 exercise price | 2016-06-07 | |
| 2016-06-03 | LEONARDI JACOPO Officer (EVP and President, Immunology) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,327 0 owned after | $32.42 exercise price | 2016-06-07 | |
| 2016-06-03 | LEONARDI JACOPO Officer (EVP and President, Immunology) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −11,263 0 owned after | $31.86 exercise price | 2016-06-07 | |
| 2016-06-03 | LEONARDI JACOPO Officer (EVP and President, Immunology) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −39,674 0 owned after | $32.04 exercise price | 2016-06-07 | |
| 2016-06-03 | LEONARDI JACOPO Officer (EVP and President, Immunology) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −230,627 0 owned after | $31.50 exercise price | 2016-06-07 | |
| 2016-06-03 | LEONARDI JACOPO Officer (EVP and President, Immunology) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −43,376 0 owned after | $31.50 exercise price | 2016-06-07 | |
| 2016-06-03 | STROUCKEN ALBERT P L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,280 0 owned after | $26.33 exercise price | 2016-06-07 | |
| 2016-06-03 | STROUCKEN ALBERT P L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,760 0 owned after | $28.95 exercise price | 2016-06-07 | |
| 2016-06-03 | STROUCKEN ALBERT P L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,680 0 owned after | $22.95 exercise price | 2016-06-07 | |
| 2016-06-03 | STROUCKEN ALBERT P L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,320 0 owned after | $20.81 exercise price | 2016-06-07 | |
| 2016-06-03 | STROUCKEN ALBERT P L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,990 0 owned after | $26.80 exercise price | 2016-06-07 | |
| 2016-06-03 | STROUCKEN ALBERT P L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,020 0 owned after | $25.30 exercise price | 2016-06-07 | |
| 2016-06-03 | STROUCKEN ALBERT P L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,930 0 owned after | $31.65 exercise price | 2016-06-07 | |
| 2016-06-03 | STROUCKEN ALBERT P L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,110 0 owned after | $34.14 exercise price | 2016-06-07 | |
| 2016-06-03 | STROUCKEN ALBERT P L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,810 0 owned after | $31.50 exercise price | 2016-06-07 | |
| 2016-06-03 | ROSA-BJORKESON DAGMAR Officer (EVP and President, Biosimilars) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −86,669 0 owned after | $33.63 exercise price | 2016-06-07 | |
| 2016-06-03 | ROSA-BJORKESON DAGMAR Officer (EVP and President, Biosimilars) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −54,553 0 owned after | $32.04 exercise price | 2016-06-07 | |
| 2016-06-03 | Edwards Peter G Officer (SVP and General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −76,202 0 owned after | $31.50 exercise price | 2016-06-07 | |
| 2016-06-03 | FOSLER GAIL D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,280 0 owned after | $26.33 exercise price | 2016-06-07 | |
| 2016-06-03 | FOSLER GAIL D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,760 0 owned after | $28.95 exercise price | 2016-06-07 | |
| 2016-06-03 | FOSLER GAIL D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,990 0 owned after | $26.80 exercise price | 2016-06-07 | |
| 2016-06-03 | FOSLER GAIL D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,020 0 owned after | $25.30 exercise price | 2016-06-07 | |
| 2016-06-03 | FOSLER GAIL D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,930 0 owned after | $31.65 exercise price | 2016-06-07 | |
| 2016-06-03 | FOSLER GAIL D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,110 0 owned after | $34.14 exercise price | 2016-06-07 | |
| 2016-06-03 | FOSLER GAIL D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,588 0 owned after | $32.15 exercise price | 2016-06-07 | |
| 2016-06-03 | FOSLER GAIL D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −293 0 owned after | $31.50 exercise price | 2016-06-07 | |
| 2016-06-03 | ORLOFF JOHN J Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −21,667 0 owned after | $34.29 exercise price | 2016-06-07 | |
| 2016-06-03 | ORLOFF JOHN J Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −88,168 0 owned after | $32.04 exercise price | 2016-06-07 | |
| 2016-06-03 | ORLOFF JOHN J Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −82,063 0 owned after | $31.50 exercise price | 2016-06-07 | |
| 2016-06-03 | FORSYTH JOHN D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,280 0 owned after | $26.33 exercise price | 2016-06-07 | |
| 2016-06-03 | FORSYTH JOHN D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,760 0 owned after | $28.95 exercise price | 2016-06-07 | |
| 2016-06-03 | FORSYTH JOHN D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,680 0 owned after | $22.95 exercise price | 2016-06-07 | |
| 2016-06-03 | FORSYTH JOHN D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,320 0 owned after | $20.81 exercise price | 2016-06-07 | |
| 2016-06-03 | FORSYTH JOHN D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,990 0 owned after | $26.80 exercise price | 2016-06-07 | |
| 2016-06-03 | FORSYTH JOHN D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,020 0 owned after | $25.30 exercise price | 2016-06-07 | |
| 2016-06-03 | FORSYTH JOHN D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,930 0 owned after | $31.65 exercise price | 2016-06-07 | |
| 2016-06-03 | FORSYTH JOHN D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,110 0 owned after | $34.14 exercise price | 2016-06-07 | |
| 2016-06-03 | FORSYTH JOHN D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,810 0 owned after | $31.50 exercise price | 2016-06-07 | |
| 2016-06-03 | Meek David D. Officer (EVP and President, Oncology) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −43,334 0 owned after | $34.29 exercise price | 2016-06-07 | |
| 2016-06-03 | Meek David D. Officer (EVP and President, Oncology) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −54,553 0 owned after | $32.04 exercise price | 2016-06-07 | |
| 2016-06-03 | Meek David D. Officer (EVP and President, Oncology) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,155 0 owned after | $31.50 exercise price | 2016-06-07 | |
| 2016-06-03 | Meek David D. Officer (EVP and President, Oncology) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −191,421 0 owned after | $31.50 exercise price | 2016-06-07 | |
| 2016-06-03 | HANTSON LUDWIG Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −84,367 0 owned after | $24.83 exercise price | 2016-06-07 | |
| 2016-06-03 | HANTSON LUDWIG Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −88,597 0 owned after | $26.53 exercise price | 2016-06-07 | |
| 2016-06-03 | HANTSON LUDWIG Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −118,953 0 owned after | $32.42 exercise price | 2016-06-07 | |
| 2016-06-03 | HANTSON LUDWIG Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −103,181 0 owned after | $31.86 exercise price | 2016-06-07 | |
| 2016-06-03 | HANTSON LUDWIG Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −287,936 0 owned after | $32.04 exercise price | 2016-06-07 | |
| 2016-06-03 | HANTSON LUDWIG Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −328,253 0 owned after | $31.50 exercise price | 2016-06-07 | |
| 2016-06-03 | HANTSON LUDWIG Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −507,380 0 owned after | $31.50 exercise price | 2016-06-07 | |
| 2016-06-03 | HOCKMEYER WAYNE T Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,500 0 owned after | $25.55 exercise price | 2016-06-07 | |
| 2016-06-03 | HOCKMEYER WAYNE T Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,760 0 owned after | $28.95 exercise price | 2016-06-07 | |
| 2016-06-03 | HOCKMEYER WAYNE T Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,680 0 owned after | $22.95 exercise price | 2016-06-07 | |
| 2016-06-03 | HOCKMEYER WAYNE T Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,320 0 owned after | $20.81 exercise price | 2016-06-07 | |
| 2016-06-03 | HOCKMEYER WAYNE T Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,990 0 owned after | $26.80 exercise price | 2016-06-07 | |
| 2016-06-03 | HOCKMEYER WAYNE T Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,020 0 owned after | $25.30 exercise price | 2016-06-07 | |
| 2016-06-03 | HOCKMEYER WAYNE T Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,930 0 owned after | $31.65 exercise price | 2016-06-07 | |
| 2016-06-03 | HOCKMEYER WAYNE T Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,110 0 owned after | $34.14 exercise price | 2016-06-07 | |
| 2016-06-03 | HOCKMEYER WAYNE T Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,588 0 owned after | $32.15 exercise price | 2016-06-07 | |
| 2016-06-03 | HOCKMEYER WAYNE T Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −293 0 owned after | $31.50 exercise price | 2016-06-07 | |
| 2016-06-03 | LAW ANNE-MARIE Officer (EVP & Head of Human Resources) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −75,835 0 owned after | $32.29 exercise price | 2016-06-07 | |
| 2016-06-03 | LAW ANNE-MARIE Officer (EVP & Head of Human Resources) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −77,146 0 owned after | $32.04 exercise price | 2016-06-07 | |
| 2016-06-03 | LAW ANNE-MARIE Officer (EVP & Head of Human Resources) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −23,447 0 owned after | $31.50 exercise price | 2016-06-07 | |
| 2016-06-03 | ZAGAME PATRICE Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −108,336 0 owned after | $33.63 exercise price | 2016-06-07 | |
| 2016-06-03 | ZAGAME PATRICE Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −88,168 0 owned after | $32.04 exercise price | 2016-06-07 | |
| 2016-06-03 | GAVIN JAMES R III Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,280 0 owned after | $26.33 exercise price | 2016-06-07 | |
| 2016-06-03 | GAVIN JAMES R III Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,760 0 owned after | $28.95 exercise price | 2016-06-07 | |
| 2016-06-03 | GAVIN JAMES R III Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,680 0 owned after | $22.95 exercise price | 2016-06-07 | |
| 2016-06-03 | GAVIN JAMES R III Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,320 0 owned after | $20.81 exercise price | 2016-06-07 | |
| 2016-06-03 | GAVIN JAMES R III Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,990 0 owned after | $26.80 exercise price | 2016-06-07 | |
| 2016-06-03 | GAVIN JAMES R III Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,020 0 owned after | $25.30 exercise price | 2016-06-07 | |
| 2016-06-03 | GAVIN JAMES R III Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,930 0 owned after | $31.65 exercise price | 2016-06-07 | |
| 2016-06-03 | GAVIN JAMES R III Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,110 0 owned after | $34.14 exercise price | 2016-06-07 | |
| 2016-06-03 | GAVIN JAMES R III Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,810 0 owned after | $31.50 exercise price | 2016-06-07 | |
| 2016-06-03 | Nader Francois Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,960 0 owned after | $30.60 exercise price | 2016-06-07 | |
| 2016-06-03 | MCCOY JOHN A. Officer (SVP and Controller) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,887 0 owned after | $26.53 exercise price | 2016-06-07 | |
| 2016-06-03 | MCCOY JOHN A. Officer (SVP and Controller) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,327 0 owned after | $32.42 exercise price | 2016-06-07 | |
| 2016-06-03 | MCCOY JOHN A. Officer (SVP and Controller) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,292 0 owned after | $31.86 exercise price | 2016-06-07 | |
| 2016-06-03 | MCCOY JOHN A. Officer (SVP and Controller) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −25,459 0 owned after | $32.04 exercise price | 2016-06-07 | |
| 2016-06-03 | MCCOY JOHN A. Officer (SVP and Controller) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −11,137 0 owned after | $31.50 exercise price | 2016-06-07 | |
| 2016-06-03 | MCCOY JOHN A. Officer (SVP and Controller) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −63,406 0 owned after | $34.63 exercise price | 2016-06-07 | |
| 2016-06-03 | Ferrante Karen Jean Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,960 0 owned after | $30.60 exercise price | 2016-06-07 | |
| 2016-06-03 | Devitt Blake E Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,280 0 owned after | $26.33 exercise price | 2016-06-07 |